Navigation Links
Cynosure to Present at 2008 Citi Investment Research Global Health Care Conference
Date:5/15/2008

Presentation to be Webcast Live at 2:00 p.m. ET Thursday, May 22

WESTFORD, Mass., May 15 /PRNewswire-FirstCall/ -- Cynosure, Inc. (Nasdaq: CYNO), a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, today announced that its senior management will present at the 2008 Citi Investment Research Global Health Care Conference, taking place at the Hilton New York.

Cynosure's presentation will be webcast live over the Internet beginning at 2:00 p.m. (ET) Thursday, May 22, 2008. President and Chief Executive Officer Michael Davin and Chief Financial Officer Timothy Baker plan to discuss Cynosure's business outlook, growth strategy and recent financial results. To access the live or archived webcast, visit the "Investor Relations" portion of Cynosure's website at http://www.cynosure.com.

About Cynosure, Inc.

Cynosure, Inc. develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular lesions, rejuvenate skin through the treatment of shallow vascular and pigmented lesions, laser lipolysis and temporarily reduce the appearance of cellulite. Cynosure's products include a broad range of laser and other light-based energy sources, including Alexandrite, pulsed dye, Nd:YAG and diode lasers, as well as intense pulsed light. Cynosure was founded in 1991. For corporate or product information, contact Cynosure at 800-886-2966, or visit http://www.cynosure.com.

Contact:

Scott Solomon

Vice President

Sharon Merrill Associates,
'/>"/>

SOURCE Cynosure, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Cynosures Accolade(TM) Workstation for Pigmented Lesions Receives Korean Regulatory Approval
2. Cynosure to Announce First-Quarter 2008 Financial Results on April 29
3. Cynosure Launches Three Aesthetic Products at American Academy of Dermatology 2008 Annual Meeting
4. CoolTouch Inc. Responds to Cynosure Patent Infringement Lawsuit
5. Cynosure Files Patent Infringement Lawsuit Against CoolTouch Inc.
6. Cynosure to Announce Third-Quarter 2007 Financial Results on November 1
7. Cynosure to Present at the Maxim Group Growth Conference
8. Alexzas Corporate Presentation to be Webcast at the Seventh Annual JMP Securities Research Conference and the 2008 Citi Investment Research Global Healthcare Conference
9. ev3 Inc. to Present at the FBR Capital Markets 12th Annual Spring Investor Conference
10. The California Dental Association Foundation Presents Inaugural Humanitarian Award to USC Mobile Dental Clinics Champion Charles M. Goldstein, DDS, MPH
11. HealthSouth to Present at the 2008 Citigroup Global Healthcare Conference and Jefferies 2nd Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... November 26, 2014 ISI Telemanagement ... solutions, has been award the 2014 Lync ... This award comes as a great honor to ... the Lync ecosystem. Specifically, ISI offers an integrated ... of Lync communication, including voice, video, Lync IM, ...
(Date:11/26/2014)... 26, 2014 Bunion Bootie, the newest ... in an early celebration of the early holiday shopping ... offered at the promotional price of $29.95 each (normally ... addition to any automatic discounts applied when buying more ... website for complete details. It’s simple: purchasing more ...
(Date:11/26/2014)... (PRWEB) November 26, 2014 Sonoran ... ANP-BC, recently received the Distinguished Preceptorship Award from ... for her role in the advancement of nurse ... of an individual who had made a significant ... NPs. The American Association of Nurse Practitioners (AANP) ...
(Date:11/26/2014)... Teens prescribed anti-anxiety or sleep medications are much ... teens, a new study warns. The findings ... on teenagers before prescribing these drugs to them, ... realize the abuse potential," said lead researcher Carol ... School of Nursing. "These drugs produce highly attractive ...
(Date:11/26/2014)... Randy Dotinga HealthDay Reporter ... such as Prilosec and Nexium may disrupt the makeup of ... infections and other problems, a small new study suggests. ... more likely users will become ill, and study authors aren,t ... However, these antacids "should be used at the lowest ...
Breaking Medicine News(10 mins):Health News:ISI Telemanagement Solutions, Inc. has been Awarded the 2014 Microsoft Lync Pioneer Award 2Health News:Bunion Bootie Temporarily Lowering Prices for Holiday Shopping, Starting Today! 2Health News:Sonoran Nurse Receives Distinguished Preceptorship Award from The American Association of Nurse Practitioners 2Health News:Teens Given Anxiety, Sleep Meds May Be at Risk for Drug Abuse 2Health News:Could Popular Heartburn Drugs Upset Your 'Good' Gut Bugs? 2Health News:Could Popular Heartburn Drugs Upset Your 'Good' Gut Bugs? 3
... HealthDay Reporter , MONDAY, April 30 (HealthDay News) -- ... disease, but most don,t know it and for most it ... has been debate about whether healthy people should be screened ... U.S. Preventive Services Task Force (USPSTF) says no. "The ...
... HealthDay Reporter , MONDAY, April 30 (HealthDay News) ... depending on where you,re treated in the United States, according ... that follow five simple strategies -- including good teamwork and ... survival rates of other medical centers, the study found. ...
... HealthDay Reporter , MONDAY, April 30 (HealthDay News) ... interferes with breast-feeding is wrong, a new small study ... born between June 2010 and August 2011, Oregon Health ... pacifiers -- also known as binkies, corks and soothers ...
... Like a police officer calling for backup while also keeping ... the brain take a two-tier approach to fighting off a ... finds. For the first time, the scientists managed to ... locked onto a model of virus-infected brain cells, while also ...
... competent than other physicians regarding knowledge of patient imaging ... The study conducted at Thomas Jefferson University in Philadelphia ... 2,685 non-radiology physicians. "On a scale of one ... patient safety was rated as 3.1 by radiologists and ...
... images from the "cloud" making it faster for them ... those physicians might be, according to a preliminary report ... academic institutions., The image share project includes the University ... Clinic in Rochester, MN, the University of Maryland in ...
Cached Medicine News:Health News:Routine Kidney Disease Screening Not Worthwhile, Experts Say 2Health News:Routine Kidney Disease Screening Not Worthwhile, Experts Say 3Health News:Heart Attack Survival Varies Widely Among Hospitals, Study Finds 2Health News:Heart Attack Survival Varies Widely Among Hospitals, Study Finds 3Health News:Pacifiers Don't Discourage Breast-Feeding, Study Says 2Health News:Pacifiers Don't Discourage Breast-Feeding, Study Says 3Health News:How does the immune system fight off threats to the brain? New research yields fresh insight 2Health News:How does the immune system fight off threats to the brain? New research yields fresh insight 3Health News:Image share project gives patients and physicians anytime, anywhere access to medical images 2
(Date:11/26/2014)... , Nov. 25, 2014 Reinforcing its commitment ... (NYSE: PHG AEX: PHIA) today ... Administration (FDA) for its IQon Spectral CT , ... first-of-its kind technology adds a new dimension to Computed ... ability to characterize structures based on their material content ...
(Date:11/26/2014)... 2014   Heska Corporation (NASDAQ: HSKA ... provider of advanced veterinary diagnostic and other specialty veterinary ... Chair, will attend The Benchmark Company, LLC,s Micro Cap Discovery ... be held at The Palmer House Hilton, 17 E. Monroe ... to 2:30 p.m. Please email hska@haydenir.com or contact ...
(Date:11/26/2014)... 2014  Breckenridge Pharmaceutical, Inc. announced today that ... with Pii (Pharmaceutics International, Inc.) ( Hunt ... Pii expect to develop and commercialize several new ... will develop, manufacture and supply the products, and ... its own label.  The drugs, comprised of four ...
Breaking Medicine Technology:Philips receives FDA 510(k) clearance for IQon Spectral CT 2Philips receives FDA 510(k) clearance for IQon Spectral CT 3Heska to Attend Benchmark Micro Cap Discovery Conference 2Breckenridge Pharmaceutical signs Multi-Product Generic Agreement with Pharmaceutics International, Inc. 2
... Cell Therapeutics, Inc. (CTI),(Nasdaq and MTA: CTIC) today announced that the following presentations,will ... formerly XYOTAX(TM)),at the 44th American Society of Clinical Oncology (ASCO) Annual Meeting,May 30 through ... Poster # ... (Abstract#) Sat., ...
... First and Only Treatment for Hunter Syndrome Now Approved in ... ... Worldwide, BASINGSTOKE, England and CAMBRIDGE, Massachusetts, May ... company, announced that ELAPRASE(R),(idursulfase), a human enzyme replacement therapy for ...
Cached Medicine Technology:Cell Therapeutics, Inc. (CTI) Announces Presentations at American Society of Clinical Oncology (ASCO) Annual Meeting 2Cell Therapeutics, Inc. (CTI) Announces Presentations at American Society of Clinical Oncology (ASCO) Annual Meeting 3Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil 2Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil 3Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil 4Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil 5
... Menicon Super EX is a rigid ... one of its specific characteristics as hard ... correction and show excellent performance against astigmatism. ... material is the combination of fluoromethacrylate, Siloxanylmethacrylate ...
Magniclear is the first presbyopic lens to combine the clear distance optics of a spherical lens, the intermediate visual performance of a multifocal and the predictably crisp, near power of a bifoca...
Boston Multivision design is manufactured in Boston ES material for early presbyope patients. Boston Multivision lens provides crisp, clear vision at near, intermediate, and far distances and excelle...
... to stain intraocular membranes in vitreoretinal surgery, ... injecting Membraneblue in an air-filled vitreous cavity, ... the dye. After removal of all excess ... can easily be distinguished from the underlying, ...
Medicine Products: